Tylenol maker, pharmacy chains urge US appeals court to revisit decision over alleged autism link
Reuters
The manufacturer of Tylenol and several pharmacy chains are asking a US appeals court to reconsider a lower court's ruling that found them potentially liable for failing to warn about a possible link between acetaminophen and autism. The companies argue that the lower court's decision was based on flawed scientific evidence and legal reasoning. The case highlights ongoing legal and scientific debates over the safety of acetaminophen during pregnancy.
All articles from 5 October 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.